Diseases · Entity Annotation Prototype (beta)

1articles mentioning diseases

2disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: CPI-R/R melanoma ×

CPI-R/R melanoma

This disease is selected. Its supporting articles are shown below.

CPI-R/R melanoma1

Articles mentioning CPI-R/R melanoma

1 articles · page 1 of 1

609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma

jitc · abstract · 2025-11-04 · 2 matching annotations

88.2%

CPI-R/R melanoma melanoma pembrolizumab mRNA-4359 Moderna, Inc.NCT05533697

…ongoing trial ( NCT05533697), as of 28Feb2025, 29 patients with CPI-R/R melanoma received pembrolizumab (400 mg IV Q6W) plus mRNA-4359 (400 µg […

Browse diseases

CPI-R/R melanoma

Articles mentioning CPI-R/R melanoma

609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma